Hidenori Azami

In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)

Aya Kikuchi, Takashi Furutani, Hidenori Azami et al. · Investigational New Drugs · 2014 · 59 citations

Medicine, Medicinal Chemistry, Pharmacology +7

A Novel Synthetic Method of the (±)-(3aα,8aα)-Ethyl 8β-Hydroxy-6β-methyl-2-oxooctahydro-2<i>H</i>-cyclohepta[<i>b</i>]furan-3α- carboxylate and Its Chemical Transformation to (±)-(3aα,8aα)-3α,6β-Dimethyl-3,3a,4,5,6,8a-hexahydro-2<i>H</i>- cyclohepta[<i>b</i>]furan-2-one, (+)- and (−)-7β-(2-Acetoxy-1α-methylethyl)-4β-methyl-2-cyclohepten-1β-ol, and (+)- and (−)-7β-(2-Acetoxy-1α-methylethyl)-4β-methyl-2-cyclohepten-1-one. Possible Common Synthetic Intermediates for Pseudoguaianolides, 4,5-Secopseudoguaianolides, Guaianolides, 4,5-Secoguaianolides, and Octalactins

Fumito Shimoma, Haruhiko Kusaka, Katsuaki Wada et al. · The Journal of Organic Chemistry · 1998 · 32 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

Studies on the Synthesis of Sesquiterpene Lactones, 12. Synthesis of (+)-Colartin, (+)-Arbusculin A and Their C-4 Epimers and Their Biological Activities

Masayoshi Ando, Koji Isogai, Hidenori Azami et al. · Journal of Natural Products · 1991 · 26 citations

Pharmacy, Botany, Medicinal Chemistry +9

Studies on Anti-Helicobacter pylori Agents. Part 1: Benzyloxyisoquinoline Derivatives

Yoshiki Yoshida, David A. Barrett, Hidenori Azami et al. · Bioorganic & Medicinal Chemistry · 1999 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems Part IV. 2-Alkyl substituents containing cationic heteroaromatics linked via a C–C bond

Hidenori Azami, David G. Barrett, Akira Tanaka et al. · Bioorganic & Medicinal Chemistry · 2001 · 17 citations

Pharmacy, Chemistry, Medicinal Chemistry +15